恰加斯病。使用血清学来确定药物疗效。价值和限制*

Q4 Immunology and Microbiology

Journal of Tropical Pathology Pub Date : 2022-01-17 DOI:10.5216/rpt.v50i4.71556

Alejandro O. Luquetti, A. Rassi

{"title":"恰加斯病。使用血清学来确定药物疗效。价值和限制*","authors":"Alejandro O. Luquetti, A. Rassi","doi":"10.5216/rpt.v50i4.71556","DOIUrl":null,"url":null,"abstract":"*Presented at the ”Consultative Meeting on the Strategic and Operational Aspects for the Clinical Development of Trypanocidal Drugs for Chagas Disease, 23-24 April 2007, Buenos Aires, Argentina.”, sponsored by TDR, WHO.\nThis publication is dedicated to one of the authors (deceased) due to his life dedicated to Chagas disease and particularly to this subject. After 14 years, this material is still valid.","PeriodicalId":36789,"journal":{"name":"Journal of Tropical Pathology","volume":"85 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chagas disease. The use of serology to establish drug efficacy. Value and limitations*\",\"authors\":\"Alejandro O. Luquetti, A. Rassi\",\"doi\":\"10.5216/rpt.v50i4.71556\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"*Presented at the ”Consultative Meeting on the Strategic and Operational Aspects for the Clinical Development of Trypanocidal Drugs for Chagas Disease, 23-24 April 2007, Buenos Aires, Argentina.”, sponsored by TDR, WHO.\\nThis publication is dedicated to one of the authors (deceased) due to his life dedicated to Chagas disease and particularly to this subject. After 14 years, this material is still valid.\",\"PeriodicalId\":36789,\"journal\":{\"name\":\"Journal of Tropical Pathology\",\"volume\":\"85 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Tropical Pathology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5216/rpt.v50i4.71556\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Immunology and Microbiology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Tropical Pathology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5216/rpt.v50i4.71556","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}

引用次数: 0

摘要

*于2007年4月23日至24日在阿根廷布宜诺斯艾利斯举行的“恰加斯病锥虫药物临床开发战略和业务问题协商会议”上发表。，由世卫组织TDR赞助。本出版物是献给其中一位作者(已故)，因为他的一生致力于恰加斯病，特别是这个主题。14年后，这份材料仍然有效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Chagas disease. The use of serology to establish drug efficacy. Value and limitations*

*Presented at the ”Consultative Meeting on the Strategic and Operational Aspects for the Clinical Development of Trypanocidal Drugs for Chagas Disease, 23-24 April 2007, Buenos Aires, Argentina.”, sponsored by TDR, WHO. This publication is dedicated to one of the authors (deceased) due to his life dedicated to Chagas disease and particularly to this subject. After 14 years, this material is still valid.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Tropical Pathology Medicine-Infectious Diseases

CiteScore

0.50

自引率

0.00%

发文量

审稿时长

8 weeks